| Name | Title | Contact Details |
|---|---|---|
Chandrika Raghavan |
Compliance Officer | Profile |
Emma Mcburney |
Executive Director, Business Development and Licensing | Profile |
F.Ty Edmondson |
Chief Corporation Counsel | Profile |
F.Ty Edmondson |
Chief Corporation Counsel | Profile |
Rakel Meir |
Chief Research Development and Operations Counsel | Profile |
Trellis Bioscience is a leader in identifying rare protective antibodies by screening human blood cells.
Aradigm Corporation is a Hayward, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Appia Bio is an early stage biotechnology company based in Los Angeles, California. Founded in 2020, Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. With its ACUA (Appia Cells Utilized for Allogeneic) technology platform, Appia Bio leverages the biology of lymphocyte development with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes from hematopoietic stem cells (HSCs).
NPS Pharmaceuticals is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
BMG Labtech is a Cary, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.